CAE State Key Laboratory of Medical Immunology develops marker-based method for liver cancer treatment by interferon

Jan 14, 2014

The team of Professor Xueta CAO found that only those hepatocellular carcinoma patients with high expression of liver retinoic acid inducible gene (RIG-I) responded well to an interferon treatment.

China Bio news release, January 14, 2013

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny